Awake prone positioning and ventilation distribution as assessed by electric impedance tomography in patients with non-COVID-19 acute hypoxemic respiratory failure: A prospective physiology study.

通过电阻抗断层扫描评估非 COVID-19 急性低氧性呼吸衰竭患者的清醒俯卧位和通气分布:一项前瞻性生理学研究

阅读:6
作者:Wang Jingjing, Chen Changxing, Zhao Zhanqi, Deng Puyu, Zhang Chenchen, Zhang Yu, Lv Hui, Chen Daonan, Xie Hui, Wang Ruilan
BACKGROUND: Awake prone positioning (APP) can reportedly reduce the need for intubation and help improve prognosis of patients with acute hypoxemic respiratory failure (AHRF) infected with COVID-19. However, its physiological mechanism remains unclear. In this study, we evaluated the effect of APP on lung ventilation in patients with moderate-to-severe AHRF to better understand the effects on ventilation distribution and to prevent intubation in non-intubated patients. METHODS: The prospective study was performed in the Department of Critical Care Medicine at Shanghai General Hospital, China, from January 2021 to November 2022. The study included patients with AHRF (partial pressure of oxygen [PaO(2)]/inspired oxygen concentration [FiO(2)] <200 mmHg or oxygen saturation [SpO(2)]/FiO(2) <235) treated with high-flow nasal oxygen. Electrical impedance tomography (EIT) measurements including center of ventilation (COV), global inhomogeneity (GI) index, and regional ventilation delay (RVD) index were performed in the supine position (T(0)), 30 min after the start of APP (T(1)), and 30 min returning to supine position after the APP (T(2)). Clinical parameters like SpO(2), respiratory rate (RR), FiO(2), heart rate (HR), and ROX (the ratio of SpO(2) as measured by pulse oximetry/FiO(2) to RR) were also recorded simultaneously at T(0), T(1), and T(2). To evaluate the effect of the time points on the variables, Mauchly's test was performed for sphericity and repeated measures analysis of variance was applied with Bonferroni's post hoc multiple comparisons. RESULTS: Ten patients were enrolled. The PaO(2)/FiO(2) ratio was (111.4±33.4) mmHg at the time of recruitment. ROX showed a significant increase after initiation of APP {median (interquartile range [IQR]): T(0): 7.5 (6.0-10.1) vs. T(1): 7.6 (6.4-9.3) vs. T(2): 8.3 (7.2-11.0), P=0.043}. RR (P=0.409), HR (P=0.417), and SpO(2)/FiO(2) (P=0.262) did not change significantly during prone positioning (PP). The COV moved from the ventral area to the dorsal area (T(0): 48.8%±6.2% vs. T(1): 54.8%±6.8% vs. T(2): 50.3%±6.1%, P=0.030) after APP. The GI decreased significantly after APP (T(0): median=42.7 %, [IQR: 38.3%-47.5%] vs. T(1): median=38.2%, [IQR: 34.6%-50.7%] vs. T(2): median=37.4%, [IQR: 34.2%-41.4%], P=0.049). RVD (P=0.794) did not change after APP. CONCLUSIONS: APP can improve ventilation distribution and homogeneity of lung ventilation as assessed by EIT in non-intubated patients with AHRF.Trail Registration Chinese Clinical Trial Registry Identifier: ChiCTR2000035895.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。